Vtv Therapeutics Stock Bond Positions Weight
| VTVT Stock | USD 14.18 0.65 4.38% |
vTv Therapeutics fundamentals help investors to digest information that contributes to VTv Therapeutics' financial success or failures. It also enables traders to predict the movement of VTv Stock. The fundamental analysis module provides a way to measure VTv Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VTv Therapeutics stock.
VTv | Bond Positions Weight |
vTv Therapeutics Company Bond Positions Weight Analysis
VTv Therapeutics' Percentage of fund asset invested in fixed income securities. About 30% of U.S. mutual funds invest in bonds.
VTv Bond Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for VTv Therapeutics is extremely important. It helps to project a fair market value of VTv Stock properly, considering its historical fundamentals such as Bond Positions Weight. Since VTv Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of VTv Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of VTv Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Funds that have over 60% of asset value invested in bonds or or other fixed income securities would usually attract conservative investors.
| Competition |
In accordance with the recently published financial statements, vTv Therapeutics has a Bond Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
VTv Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, VTv Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to VTv Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
VTv Fundamentals
| Return On Equity | -3.62 | ||||
| Return On Asset | -0.41 | ||||
| Operating Margin | (22.86) % | ||||
| Current Valuation | (4.32 M) | ||||
| Shares Outstanding | 2.61 M | ||||
| Shares Owned By Insiders | 38.82 % | ||||
| Shares Owned By Institutions | 14.95 % | ||||
| Number Of Shares Shorted | 28.85 K | ||||
| Price To Earning | (4.19) X | ||||
| Price To Book | 2.47 X | ||||
| Price To Sales | 37.04 X | ||||
| Revenue | 9 K | ||||
| Gross Profit | (9.93 M) | ||||
| EBITDA | (25.41 M) | ||||
| Net Income | (20.25 M) | ||||
| Cash And Equivalents | 17.95 M | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 529 K | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.12 X | ||||
| Book Value Per Share | (11.84) X | ||||
| Cash Flow From Operations | (19.08 M) | ||||
| Short Ratio | 1.50 X | ||||
| Earnings Per Share | (4.37) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 37.04 M | ||||
| Total Asset | 11.02 M | ||||
| Retained Earnings | (281.04 M) | ||||
| Working Capital | 38 K | ||||
| Current Asset | 52.12 M | ||||
| Current Liabilities | 10.58 M | ||||
| Net Asset | 11.02 M |
About VTv Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze vTv Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VTv Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of vTv Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.